Esoteric Testing Market Present Scenario, Future Trends and Forecast 2018-2024

The Esoteric Testing Market size is set to exceed USD 35 billion by 2024; according to a new research report by Global Market Insights.

Increasing prevalence of chronic diseases and infectious diseases in developing countries such as China along with rising geriatric population, highly susceptible to suffer from chronic disorders will drive esoteric testing market over the forecast timeframe.

Rising number of people suffering from rare diseases has escalated burden on healthcare systems to develop innovative test solutions, thereby fueling industry growth. Furthermore, sophistication of laboratory equipment leading to growing adoption of ground breaking technologies such as flow cytometry, mass spectrometry and real time-PCR will favor industry growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1922

Growing awareness about early disease detection along with rising demand for genomics and proteomic will positively impact esoteric testing market growth over the forecast period. However, lack of trained professionals and stringent regulations related with esoteric tests will restrain industry growth in future.

Browse key industry insights spread across 160 pages with 132 market data tables & 8 figures & charts from the report, “Esoteric Testing Market Size By Test Type (Endocrinology, Infectious Disease & Immunology, Oncology, Toxicology, Neurology, Genomics), By Technology (Mass Spectrometry, Flow Cytometry, ELISA, Radioimmunoassay, Chemiluminescence, Real Time-PCR), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024” in detail along with the table of contents.

Infectious disease business segment dominated the esoteric testing market in 2017 with around 28% market share followed by endocrinology, anticipated to witness considerable growth over the coming years. Rising incidences of infectious diseases coupled with growing demand for advanced molecular tests for identifying rare molecules present in the body will drive segment growth. Rising awareness about pre-disease diagnosis and treatment will further stimulate demand for esoteric tests over the coming years.

RT-PCR business segment of esoteric testing market is estimated to witness around 9.6% CAGR growth over the forecast period. Growing adoption and application of real-time PCR as compared to other conventional techniques due to its superior specificity, sensitivity and speed with reduced contamination risk will drive segment growth. Technological advancements in field of PCR coupled with growing investments towards PCR-based research will further propel business growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1922

Germany esoteric testing market should grow with more than 8.5% CAGR growth rate owing to increasing incidences of rare and complex diseases and high cutting edge technological adoption. Germany has well developed National Rare Disease Plan with centralized core programs for neonatal screening, national funding, access to treatments, robust research plans, coordinated networks and cross-border collaborations for rare diseases should propel industry growth.

Developing healthcare infrastructure, growing awareness about early disease detection and numerous initiatives undertaken by government will drive Indian esoteric testing market. Initiatives such as action plan to eradicate Visceral leishmaniasis (VL) by 2017 undertaken by government will fuel industry growth. Furthermore, increasing elderly population in the country will stimulate demand for esoteric tests over the coming years.

Some of the key industry players operating in global esoteric testing market are Laboratory Corporation of America, Quest Diagnostics, Opko Health, and Arup Laboratories. Other players include Mayo Medical Laboratories, ACM Global Laboratories, American Esoteric Laboratories (AEL), Fulgent Genetics, Invitae, Myriad Genetics, Nordic Laboratories, Miraca Holdings, Genomic Health, BioMONTR. The industry players are focusing towards elevating their market position by adopting various inorganic growth strategies such as acquisition and strategic partnership. For instance, Opko Health acquired Bio-Reference Laboratory, third largest clinical laboratory in August 2015 to expand company’s product portfolio, thereby consolidating market position.

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.